Summary
This prediction ended on 14.12.22 with a price of €0.82. The BUY prediction by krebskrebs for Englobal performed very badly with a performance of -39.49%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Englobal | - | - | - |
iShares Core DAX® | -2.926% | -3.811% | 9.621% |
iShares Nasdaq 100 | 4.462% | 7.635% | 33.690% |
iShares Nikkei 225® | 0.306% | -0.065% | 4.201% |
iShares S&P 500 | 2.488% | 4.185% | 27.301% |
Comments by krebskrebs for this prediction
In the thread Englobal diskutieren
Buy mit Kursziel 2,5
In the thread Trading Englobal
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten